Biotechnology Analysis & Statistics in the United States, December 2014

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: Flow Cytometry, Hematology, Biotech, more »

1-30 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

  • $ 4 650
  • Industry report
  • November 2014
  • by MarketsandMarkets

The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : World, Europe, North America, Switzerland, France, Germany, United States, Canada, Denmark, Japan, China, Asia
PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

  • $ 2 995
  • Industry report
  • November 2014
  • by Global Data

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy Summary GlobalData's report "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, Japan, India, China, Asia, World
Pharmacogenomics Partnering Terms and Agreements

Pharmacogenomics Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • November 2014
  • by Currentpartnering

The Pharmacogenomics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the worlds ...

  • Industries : Genomics
  • Countries : United States
Immune Checkpoint Inhibitors Market, 2014-2024

Immune Checkpoint Inhibitors Market, 2014-2024

  • $ 1 899
  • Industry report
  • November 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although cancer therapeutics ...

  • Industries : Biopharmaceutical
  • Countries : United States
Industry Financial Review of the Global Laboratory Research Tools Market

Industry Financial Review of the Global Laboratory Research Tools Market

  • $ 1 500
  • Industry report
  • October 2014
  • by Frost & Sullivan

Cautious Optimism for Continued Recovery This study provides an analysis of the global laboratory research tools market, segmented by the United States (US), Canada, Europe, Japan, India, China, Brazil, ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Genetic Testing Market Outlook 2018

Genetic Testing Market Outlook 2018

  • $ 1 400
  • Industry report
  • October 2014
  • by RNCOS

A recent report, “Genetic Testing Market Outlook 2018”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working ...

  • Industries : Genomics
  • Countries : United States, World
Global Antibody Drug Conjugate Market Outlook 2018

Global Antibody Drug Conjugate Market Outlook 2018

  • $ 1 200
  • Industry report
  • November 2014
  • by RNCOS

For more than a century, the concept of a “magic bullet” to deliver cytotoxic therapy to the site of tumor has been envisioned, but only recently the technological advances enabled antibody-drug conjugates ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biosimilars Business Review Q4 2014

Biosimilars Business Review Q4 2014

  • $ 1 114
  • Industry report
  • December 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - US Biosimilar Market Edged Closer In 2014, Intensifying Key Debates Industry Brief - Epirus Enters China Collaboration With Livzon Industry Trend Analysis - Amgen's Biosimila ...

  • Industries : Biopharmaceutical
  • Countries : India, China, United States, World
Biotechnology Market in the United States

Biotechnology Market in the United States

  • $ 1 020
  • Industry report
  • November 2014
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's May Biotechnology in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry Risk Ratings report ...

  • Industries : Biopharmaceutical
  • Countries : United States
Seattle Genetics Partnering 2009-2014

Seattle Genetics Partnering 2009-2014

  • $ 995
  • Company report
  • November 2014
  • by Currentpartnering

The Partnering Agreements with Seattle Genetics 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. This report ...

  • Industries : Genomics
  • Countries : United States
11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

  • $ 895
  • Industry report
  • December 2014
  • by BioPlan Associates, Inc.

The 2014 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current ...

  • Industries : Biopharmaceutical
  • Countries : United States, Europe, World
Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Calypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis ...

  • Industries : Biopharmaceutical
  • Countries : United States
Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2014 Update

Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • November 2014
  • by Global Data

Summary Vermillion, Inc. (Vermillion) is a healthcare service provider. The company develops and commercializes multi-marker, diagnostic tests, which addresses unmet needs in gynecologic oncology and women's ...

  • Industries : Genomics
  • Countries : United States
Brain Resource Limited (BRC) - Product Pipeline Analysis, 2014 Update

Brain Resource Limited (BRC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by Global Data

Summary Brain Resource Limited (BRL) is a healthcare service provider. The company carries out research and development of brain products. Its products include MyBrainSolutions, MyCalmBeat, WebNeuro and ...

  • Industries : Genomics
  • Countries : Australia, United States
Physician Views: What opportunity for biosimilar basal insulin?

Physician Views: What opportunity for biosimilar basal insulin?

  • $ 681
  • Industry report
  • November 2014
  • by Firstword Pharma

Two weeks ago, Sanofi significantly downgraded internal revenue projections for Lantus, its long-acting basal insulin treatment, which generated annual sales of $7.6 billion in 2013. The company no longe ...

  • Industries : Biopharmaceutical
  • Countries : United States
Physician Views: Biosimilar Lucentis - what opportunity?

Physician Views: Biosimilar Lucentis - what opportunity?

  • $ 645
  • Industry report
  • October 2014
  • by Firstword Pharma

With the initial focus of biosimilar antibody developers very much sharpened on the markets for TNF inhibitors (Remicade, Humira) and leading cancer MAbs (Herceptin, Rituxan, Avastin), the opportunity ...

  • Industries : Biopharmaceutical
  • Countries : United States
Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
  • Countries : United States
Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
BioMedical Technology Solutions Holdings, Inc. (Symbol:BMTL) SWOT Analysis, Strategy, Revenues and Profits

BioMedical Technology Solutions Holdings, Inc. (Symbol:BMTL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Genitope Corporation (Genitope) is a publicly held US based biotechnology company. It is focused on the research and development (R&D) of novel immunotherapies for the treatment of cancer. The ...

  • Industries : Biological Therapy
  • Countries : United States
Igene Biotechnology, Inc. (Symbol:IGNE) SWOT Analysis, Strategy, Revenues and Profits

Igene Biotechnology, Inc. (Symbol:IGNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
Gadot Biochemical Industries Ltd. - Strategic SWOT Analysis Review

Gadot Biochemical Industries Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Gadot Biochemical Industries Ltd. (GBI) is a chemical manufacturing company. The company manufactures chemicals for the food, beverage, nutritional supplement, pharmaceutical, and detergent industries. ...

  • Industries : Biotechnology
  • Countries : Netherlands, United States, Israel
CellCyte Genetics Corporation (CCYG) - Financial and Strategic SWOT Analysis Review

CellCyte Genetics Corporation (CCYG) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary CellCyte Genetics Corporation is a biotechnology company. The company is focused on the development and commercialization of cell expansion and maintenance using its patented technology. The company ...

  • Industries : Genomics
  • Countries : United States
Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Taiwan, Japan
American Biosystems, Inc. SWOT Analysis, Strategy, Revenues and Profits

American Biosystems, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
Applied DNA Sciences, Inc. (Symbol:APDN) SWOT Analysis, Strategy, Revenues and Profits

Applied DNA Sciences, Inc. (Symbol:APDN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Canada, United Kingdom
Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
BioTransplant Inc. SWOT Analysis, Strategy, Revenues and Profits

BioTransplant Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States

10 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.